A Phase 3, Open-Label, Multicentre Study of Flurpiridaz (18F) Injection for Positron Emission Tomography (PET) Imaging for Assessment of Myocardial Perfusion in Patients Referred for Invasive Coronary Angiography BC of Suspected Coronary Artery Disease
This is a Phase 3, prospective, open-label, international, multicentre study of Flurpiridaz (18F) Injection for PET MPI in patients referred for ICA because of suspected CAD.
PI: Dr. Medhat Osman
Study Coordinator: Kelly Reno
This study is currently enrolling. To learn more about AURORA and how you can join contact our research office at (314) 289-7690.